ANDA 70533, held by Apothecon. Fluphenazine Hydrochloride.
As of Nov 16, 2026, ANDA 70533 (Prolixin), held by Apothecon, was first approved by FDA on Nov 7, 1985, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 7, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prolixin5MG/ML · concentrate;oral | Fluphenazine Hydrochloride | Discontinued |
| Mar 4, 1996 | Supplement 11Manufacturing | Approved | None posted |
| Apr 16, 1993 | Supplement 10Manufacturing | Approved | None posted |
| Oct 5, 1987 | Supplement 8Labeling | Approved | None posted |
| Oct 5, 1987 | Supplement 7Labeling | Approved | None posted |
| Oct 5, 1987 | Supplement 6Labeling | Approved | None posted |
| Mar 10, 1987 | Supplement 5Labeling | Approved | None posted |
| Jun 6, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Mar 25, 1986 | Supplement 3Labeling | Approved | None posted |
| Mar 20, 1986 | Supplement 2Labeling | Approved | None posted |
| Mar 20, 1986 | Supplement 1Manufacturing | Approved | None posted |
| Nov 7, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters